BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 27609028)

  • 1. Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis.
    Lourtet-Hascoët J; Bicart-See A; Félicé MP; Giordano G; Bonnet E
    Int J Infect Dis; 2016 Oct; 51():56-61. PubMed ID: 27609028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus versus Staphylococcus epidermidis in periprosthetic joint infection-Outcome analysis of methicillin-resistant versus methicillin-susceptible strains.
    Hischebeth GT; Randau TM; Ploeger MM; Friedrich MJ; Kaup E; Jacobs C; Molitor E; Hoerauf A; Gravius S; Wimmer MD
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):125-130. PubMed ID: 30266398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.
    Trobos M; Firdaus R; Svensson Malchau K; Tillander J; Arnellos D; Rolfson O; Thomsen P; Lasa I
    Microbiol Spectr; 2022 Aug; 10(4):e0218121. PubMed ID: 35762769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
    Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
    Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci.
    Tornero E; García-Oltra E; García-Ramiro S; Martínez-Pastor JC; Bosch J; Climent C; Morata L; Camacho P; Mensa J; Soriano A
    Int J Artif Organs; 2012 Oct; 35(10):884-92. PubMed ID: 23138701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofilm formation is associated with poor outcome in prosthetic joint infections caused by
    Hagstrand Aldman M; Thompson O; Påhlman LI
    Infect Dis (Lond); 2023 May; 55(5):328-332. PubMed ID: 36799228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic and phenotypic changes of Staphylococcus epidermidis during relapse episodes in prosthetic joint infections.
    Ortega-Peña S; Franco-Cendejas R; Aquino-Andrade A; Betanzos-Cabrera G; Sharma A; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
    Braz J Microbiol; 2020 Jun; 51(2):601-612. PubMed ID: 31828715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.
    Leijtens B; Elbers JBW; Sturm PD; Kullberg BJ; Schreurs BW
    BMC Infect Dis; 2017 May; 17(1):321. PubMed ID: 28464821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the microbial pattern of periprosthetic joint infections of the hip and knee.
    Rosteius T; Jansen O; Fehmer T; Baecker H; Citak M; Schildhauer TA; Geßmann J
    J Med Microbiol; 2018 Nov; 67(11):1608-1613. PubMed ID: 30207518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
    Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
    APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosthetic joint infection due to Staphylococcus lugdunensis.
    Sampathkumar P; Osmon DR; Cockerill FR
    Mayo Clin Proc; 2000 May; 75(5):511-2. PubMed ID: 10807080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study.
    Achermann Y; Eigenmann K; Ledergerber B; Derksen L; Rafeiner P; Clauss M; Nüesch R; Zellweger C; Vogt M; Zimmerli W
    Infection; 2013 Apr; 41(2):431-7. PubMed ID: 22987291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of vascular graft infection caused by Staphylococcus lugdunensis after femoropopliteal bypass operation.
    Hagiya H; Matsumoto M; Yamasawa T; Haruki Y; Otsuka F
    Acta Med Okayama; 2014; 68(3):171-5. PubMed ID: 24942796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Outcomes of Staphylococcus lugdunensis Prosthetic Joint Infections: A Multicenter Retrospective Analysis.
    Masood K; Redfern RE; Duggan JM; Georgiadis GM; Suleyman G
    Orthopedics; 2020 Nov; 43(6):345-350. PubMed ID: 33002183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
    Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
    Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis.
    Argemi X; Prévost G; Riegel P; Keller D; Meyer N; Baldeyrou M; Douiri N; Lefebvre N; Meghit K; Ronde Oustau C; Christmann D; Cianférani S; Strub JM; Hansmann Y
    Clin Microbiol Infect; 2017 May; 23(5):334.e1-334.e8. PubMed ID: 28017792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the prognosis the same for periprosthetic joint infections due to Staphylococcus aureus versus coagulase-negative staphylococci? A retrospective study of 101 patients with 2-year minimum follow-up.
    Murgier J; Laffosse JM; Cailliez J; Cavaignac E; Murgier P; Bayle-Iniguez X; Chiron P; Bonnevialle P
    Arch Orthop Trauma Surg; 2016 Oct; 136(10):1357-61. PubMed ID: 27481366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus lugdunensis: a neglected pathogen of infections involving fracture-fixation devices.
    Seng P; Traore M; Lavigne JP; Maulin L; Lagier JC; Thiery JF; Levy PY; Roger PM; Bonnet E; Sotto A; Stein A
    Int Orthop; 2017 Jun; 41(6):1085-1091. PubMed ID: 28405808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections.
    Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
    J Antibiot (Tokyo); 2012 Oct; 65(10):505-8. PubMed ID: 22854340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 92 protein inflammation panel performed on sonicate fluid differentiates periprosthetic joint infection from non-infectious causes of arthroplasty failure.
    Fisher CR; Salmons HI; Mandrekar J; Greenwood-Quaintance KE; Abdel MP; Patel R
    Sci Rep; 2022 Sep; 12(1):16135. PubMed ID: 36167782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.